These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6507453)

  • 21. Animal model for theophylline--cimetidine drug interaction.
    Ritschel WA; Banerjee PS; Cacini W; Hassan M; Pesce AJ
    Methods Find Exp Clin Pharmacol; 1985 Dec; 7(12):627-9. PubMed ID: 3831635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
    Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
    Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fatal case of theophylline intoxication.
    Anderson JR; Poklis A; Slavin RG
    Arch Intern Med; 1983 Mar; 143(3):559-60. PubMed ID: 6830388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computer-assisted practitioner-response system for studying the use of cimetidine.
    Schwartz JI; Kennedy TJ
    Am J Hosp Pharm; 1982 Jul; 39(7):1198-201. PubMed ID: 7114066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential drug interactions in surgical patients.
    Durrence CW; DiPiro JT; May JR; Nesbit RR; Sisley JF; Cooper JW
    Am J Hosp Pharm; 1985 Jul; 42(7):1553-6. PubMed ID: 4025352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions avoided-a useful indicator of good prescribing practice.
    Williams D; Kelly A; Feely J
    Br J Clin Pharmacol; 2000 Apr; 49(4):369-72. PubMed ID: 10759693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cimetidine-theophylline complex formation.
    Ritschel WA; Alcorn GJ; Streng WH; Zoglio MA
    Methods Find Exp Clin Pharmacol; 1983; 5(1):55-8. PubMed ID: 6855344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of repeat dosing with cimetidine on the pharmacokinetics of intravenous granisetron in healthy volunteers.
    Youlten L
    J Pharm Pharmacol; 2004 Feb; 56(2):169-75. PubMed ID: 15005875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of concurrent use of warfarin with potentially interacting drugs.
    Wittkowsky AK; Boccuzzi SJ; Wogen J; Wygant G; Patel P; Hauch O
    Pharmacotherapy; 2004 Dec; 24(12):1668-74. PubMed ID: 15585436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.
    Smith SR; Kendall MJ
    Clin Pharmacokinet; 1988 Jul; 15(1):44-56. PubMed ID: 3042245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
    Londong W; Londong V; Prechtl R; Weber T; von Werder K
    Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interactions involving cimetidine--mechanisms, documentation, implications.
    Greene W
    Q Rev Drug Metab Drug Interact; 1984; 5(1):25-51. PubMed ID: 6152350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
    Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
    Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cimetidine use and risk of prostate and breast cancer.
    Rossing MA; Scholes D; Cushing-Haugen KL; Voigt LF
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):319-23. PubMed ID: 10750671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro availability studies of enoxacin in presence of H2 receptor antagonists.
    Arayne MS; Sultana N; Haroon U; Hamza E
    Pak J Pharm Sci; 2007 Jul; 20(3):235-43. PubMed ID: 17545110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug interactions of ciprofloxacin with other non-antibiotic agents.
    Rubinstein E; Segev S
    Am J Med; 1987 Apr; 82(4A):119-23. PubMed ID: 3555026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline.
    Hamilton RA; Gordon T
    Ann Pharmacother; 1992 Dec; 26(12):1507-11. PubMed ID: 1482803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential drug interactions with H2-receptor antagonists in intensive care unit patients.
    Monaghan MS; Falls L; Olsen KM
    Hosp Pharm; 1993 Apr; 28(4):296-7, 300-1, 305 passim. PubMed ID: 10136586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.